Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5WMX

Structural Insights into Substrate and Inhibitor Binding Sites in Human Indoleamine 2,3-Dioxygenase 1

Summary for 5WMX
Entry DOI10.2210/pdb5wmx/pdb
Related5WMU 5WMV 5WMW
DescriptorIndoleamine 2,3-dioxygenase 1, CYANIDE ION, PROTOPORPHYRIN IX CONTAINING FE, ... (6 entities in total)
Functional Keywordsdioxygenase tryptophan heme inhibitor, oxidoreductase
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight97419.45
Authors
Lewis-Ballester, A.,Yeh, S.R.,Pham, K.N.,Batabyal, D.,Karkashon, S.,Bonanno, J.B.,Poulos, T.M. (deposition date: 2017-07-31, release date: 2017-12-06, Last modification date: 2024-11-06)
Primary citationLewis-Ballester, A.,Pham, K.N.,Batabyal, D.,Karkashon, S.,Bonanno, J.B.,Poulos, T.L.,Yeh, S.R.
Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1.
Nat Commun, 8:1693-1693, 2017
Cited by
PubMed Abstract: Human indoleamine 2,3-dioxygenase 1 (hIDO1) is an attractive cancer immunotherapeutic target owing to its role in promoting tumoral immune escape. However, drug development has been hindered by limited structural information. Here, we report the crystal structures of hIDO1 in complex with its substrate, Trp, an inhibitor, epacadostat, and/or an effector, indole ethanol (IDE). The data reveal structural features of the active site (Sa) critical for substrate activation; in addition, they disclose a new inhibitor-binding mode and a distinct small molecule binding site (Si). Structure-guided mutation of a critical residue, F270, to glycine perturbs the Si site, allowing structural determination of an inhibitory complex, where both the Sa and Si sites are occupied by Trp. The Si site offers a novel target site for allosteric inhibitors and a molecular explanation for the previously baffling substrate-inhibition behavior of the enzyme. Taken together, the data open exciting new avenues for structure-based drug design.
PubMed: 29167421
DOI: 10.1038/s41467-017-01725-8
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.69 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon